97 related articles for article (PubMed ID: 20584624)
1. Analysis of causal models of diet for patients with head and neck cancer receiving radiation therapy.
Ogama N; Suzuki S; Yasui Y; Azenishi K; Shimizu Y
Eur J Oncol Nurs; 2010 Sep; 14(4):291-8. PubMed ID: 20584624
[TBL] [Abstract][Full Text] [Related]
2. Development of an oral assessment tool to evaluate appetite in patients with head and neck cancer receiving radiotherapy.
Ogama N; Ogama N
Eur J Oncol Nurs; 2013 Aug; 17(4):474-81. PubMed ID: 23164924
[TBL] [Abstract][Full Text] [Related]
3. Appetite and adverse effects associated with radiation therapy in patients with head and neck cancer.
Ogama N; Suzuki S; Umeshita K; Kobayashi T; Kaneko S; Kato S; Shimizu Y
Eur J Oncol Nurs; 2010 Feb; 14(1):3-10. PubMed ID: 19734089
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
[No Abstract] [Full Text] [Related]
5. Adverse effects and appetite suppression associated with particle beam therapy in patients with head and neck cancer.
Ogama N; Suzuki S
Jpn J Nurs Sci; 2012 Jun; 9(1):28-37. PubMed ID: 22583938
[TBL] [Abstract][Full Text] [Related]
6. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
[TBL] [Abstract][Full Text] [Related]
7. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
8. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.
Wijers OB; Levendag PC; Braaksma MM; Boonzaaijer M; Visch LL; Schmitz PI
Head Neck; 2002 Aug; 24(8):737-47. PubMed ID: 12203798
[TBL] [Abstract][Full Text] [Related]
9. [Oral secondary effects of radiotherapy and chemotherapy in cancer of the cervicofacial region].
Bascones-Martínez A; Muñoz-Corcuera M; Gómez-Font R
Med Clin (Barc); 2013 Jul; 141(2):77-81. PubMed ID: 23664688
[No Abstract] [Full Text] [Related]
10. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Duncan GG; Epstein JB; Tu D; El Sayed S; Bezjak A; Ottaway J; Pater J;
Head Neck; 2005 May; 27(5):421-8. PubMed ID: 15782422
[TBL] [Abstract][Full Text] [Related]
11. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
[TBL] [Abstract][Full Text] [Related]
12. Dental management of the patient receiving radiation therapy for head and neck cancer.
Reynolds WR
SCADA J; 1982; 2():79-85. PubMed ID: 6219452
[No Abstract] [Full Text] [Related]
13. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
[TBL] [Abstract][Full Text] [Related]
14. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
Vacha P; Marx M; Engel A; Richter E; Feyerabend T
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
[TBL] [Abstract][Full Text] [Related]
15. The changed meaning of food: Physical, social and emotional loss for patients having received radiation treatment for head and neck cancer.
McQuestion M; Fitch M; Howell D
Eur J Oncol Nurs; 2011 Apr; 15(2):145-51. PubMed ID: 20864401
[TBL] [Abstract][Full Text] [Related]
16. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
[TBL] [Abstract][Full Text] [Related]
17. A study to evaluate nurse-led on-treatment review for patients undergoing radiotherapy for head and neck cancer.
Wells M; Donnan PT; Sharp L; Ackland C; Fletcher J; Dewar JA
J Clin Nurs; 2008 Jun; 17(11):1428-39. PubMed ID: 18093117
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
[TBL] [Abstract][Full Text] [Related]
19. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
[TBL] [Abstract][Full Text] [Related]
20. Oral candidiasis in patients receiving radiation therapy for head and neck cancer.
Deng Z; Kiyuna A; Hasegawa M; Nakasone I; Hosokawa A; Suzuki M
Otolaryngol Head Neck Surg; 2010 Aug; 143(2):242-7. PubMed ID: 20647128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
